You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

McKesson
Dow
Express Scripts
Johnson and Johnson
Harvard Business School
Boehringer Ingelheim

Last Updated: May 10, 2021

DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR CARIPRAZINE HYDROCHLORIDE

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

All Clinical Trials for Cariprazine Hydrochloride

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00839852 The Purpose of the Study is to Determine Whether Cariprazine is a Safe and Tolerated Long-term Treatment in Patients With Chronic Stable Schizophrenia Completed Gedeon Richter Ltd. Phase 2 2009-05-01 This is an outpatient study to evaluate the long-term safety, tolerability, and pharmacokinetics of cariprazine in patients with Schizophrenia.
NCT00839852 The Purpose of the Study is to Determine Whether Cariprazine is a Safe and Tolerated Long-term Treatment in Patients With Chronic Stable Schizophrenia Completed Forest Laboratories Phase 2 2009-05-01 This is an outpatient study to evaluate the long-term safety, tolerability, and pharmacokinetics of cariprazine in patients with Schizophrenia.
NCT00852202 Safety and Efficacy of RGH-188 (Cariprazine) in Bipolar Depression Completed Gedeon Richter Ltd. Phase 2 2009-06-01 The purpose of this study is to evaluate the efficacy, safety, and tolerability of cariprazine in the treatment of outpatients with bipolar depression.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for Cariprazine Hydrochloride

Condition Name

Condition Name for Cariprazine Hydrochloride
Intervention Trials
Schizophrenia 10
Major Depressive Disorder 7
Bipolar I Disorder 6
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for Cariprazine Hydrochloride
Intervention Trials
Disease 13
Depressive Disorder 12
Depression 12
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for Cariprazine Hydrochloride

Trials by Country

Trials by Country for Cariprazine Hydrochloride
Location Trials
United States 379
India 28
Ukraine 20
Romania 13
Russian Federation 10
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for Cariprazine Hydrochloride
Location Trials
California 26
Florida 23
Texas 23
Ohio 23
Georgia 19
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for Cariprazine Hydrochloride

Clinical Trial Phase

Clinical Trial Phase for Cariprazine Hydrochloride
Clinical Trial Phase Trials
Phase 3 20
Phase 2 8
Phase 1 3
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for Cariprazine Hydrochloride
Clinical Trial Phase Trials
Completed 16
Not yet recruiting 7
Recruiting 7
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for Cariprazine Hydrochloride

Sponsor Name

Sponsor Name for Cariprazine Hydrochloride
Sponsor Trials
Forest Laboratories 19
Gedeon Richter Ltd. 15
Allergan 7
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for Cariprazine Hydrochloride
Sponsor Trials
Industry 43
Other 3
NIH 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Colorcon
McKinsey
Moodys
AstraZeneca
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.